Loh

ABSTRACT Introduction Late-onset hypogonadism is a clinical entity characterized by low testosterone concentrations associated with clinical symptoms in the absence of organic disease in aging men. It has been associated with metabolic syndrome, reduced bone mineral density, and increased...

Male Reproduction and Aging (2023) Maria Gabriela Figueiredo, MD, Thiago Gagliano-Jucá, MD, PhD, Shehzad Basaria, MD INTRODUCTION Aging of humans is associated with functional alterations at all levels of the reproductive axis and affects both steroidogenic and spermatogenic compartments...

A Systematic Review of Studies Assessing Efficacy and Cardiovascular Safety of Testosterone Replacement Therapy in Men with Late‑onset Hypogonadism Due to Obesity ± Type 2 Diabetes Mellitus (2023) Vinod Abichandani, Atul Kalhan Background: There is a lack of consensus regarding the efficacy...

Aging and androgens: Physiology and clinical implications (2022) Bradley D. Anawalt · Alvin M. Matsumoto Abstract In men> ~35 years, aging is associated with perturbations in the hypothalamus-pituitary–testicular axis and declining serum testosterone concentrations. The major changes are...

Novel testosterone gel improves serum testosterone concentrations and aging males’ symptoms in patients with late-onset hypogonadism: an active control equivalence, randomized, double-blind, crossover study (2022) Masato Shirai, Akira Tsujimura, Kazuhiko Mizushima, Takamitsu Tsuru, Makoto...

https://grandroundsinurology.com/presentations-from-the-32nd-annual-international-prostate-cancer-update/#session2 SESSION 2: Androgen Society Presentations (2022)